Chris Degnan
Chief Financial Officer at UroGen Pharma · 4 reported transactions in 1 company · latest trade Oct 8, 2026
Their trades
Sold | Oct 8, 2026 | Oct 8, 2026 close $36.98 → Oct 30, 2026 close $32.72. S&P 500 −2.4% over the same days. | ||
Sold | Oct 8, 2025 | Oct 8, 2025 close $17.33 → Oct 30, 2026 close $32.72. S&P 500 +12.3% over the same days. |
SoldUroGen Pharma
$80.8K
Oct 8, 2026 close $36.98 → Oct 30, 2026 close $32.72. S&P 500 −2.4% over the same days.
SoldUroGen Pharma
$37.1K
Oct 8, 2025 close $17.33 → Oct 30, 2026 close $32.72. S&P 500 +12.3% over the same days.